Skip to content
Screener

Precigen PGEN Net gains (losses) on investments

Net gains (losses) on investments at other companies

Gilead Sciences logo
Gilead SciencesGILD
$253M+301%
Opko Health logo
Opko HealthOPK
$0
Arrowhead Research logo
Arrowhead ResearchARWR
-$6.72M
ALN
Alnylam PharmaceuticalsALNY
$0+100%
Amgen logo
AmgenAMGN
-$158M
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$1.75M+60.8%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.51B+388%
Enterprise value$2.6B+414%
P/S94.4×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Net loss$(7,929)$(54,153)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization1,099629
Change in fair value of warrant liabilities32,481
Amortization of discounts on investments, net(369)(706)
Stock-based compensation expense3,0062,677
Shares issued as payment for services526527
Accretion of debt discount and amortization of deferred financing costs345

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's net gains (losses) on investments?
Precigen (PGEN) reported net gains (losses) on investments of $0 in Q1 2026.
How has Precigen's net gains (losses) on investments changed year-over-year?
Precigen's net gains (losses) on investments increased by 100.0% year-over-year, from -$32.48M to $0.
What is the long-term trend for Precigen's net gains (losses) on investments?
Over 2 years (2022 to 2024), Precigen's net gains (losses) on investments has grown at a -100.0% compound annual growth rate (CAGR), from $862K to $0.
What does net gains (losses) on investments mean?
Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.

Ask your AI about Precigen's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude